Zobrazeno 1 - 10
of 18
pro vyhledávání: '"D L Sprecher"'
Autor:
D L Sprecher, J Kobayashi, M Rymaszewski, IJ Goldberg, BV Harris, PS Bellet, D Ameis, R L Yunker, DM Black, EA Stein
Publikováno v:
Journal of Lipid Research, Vol 33, Iss 6, Pp 859-866 (1992)
A lipoprotein lipase (LpL) gene defect has been identified, a G—-A transition at nucleotide position 446 of exon 3, resulting in a premature termination codon (Trp—-stop) at amino acid residue 64. This defect was identified in a Type I hyperlipop
Externí odkaz:
https://doaj.org/article/920e1d9804774ed4a173f26ff9632a45
Publikováno v:
Journal of Lipid Research, Vol 29, Iss 3, Pp 273-278 (1988)
Apolipoprotein (apo) C-II deficiency is characterized by elevated plasma triglycerides, chylomicrons, and very low density lipoproteins, as well as reduced levels of low density and high density lipoproteins. A subject with apoC-II deficiency has bee
Externí odkaz:
https://doaj.org/article/aaa322597e3e463884cf05bdd972e1d3
Publikováno v:
American Journal of Public Health. 89:1708-1714
OBJECTIVES: This study was done to assess changes in obesity and risk factors for cardiovascular disease (CVD) in Black and White children from 1975 through 1990. METHODS: A cross-sectional study of body composition and CVD risk factors conducted in
Publikováno v:
Cleveland Clinic Journal of Medicine. 63:275-279
Should cardiologists, internists, or nurse practitioners lead prevention efforts? What is the role of diet in the era of the statins?
Publikováno v:
The Journal of heart valve disease. 10(1)
Hyperlipidemia is a risk factor for the progression of coronary artery disease, and possibly also valvular aortic stenosis. Thus, patients with aortic stenosis, coronary disease (or both) might be expected to have more abnormal lipid profiles than th
Autor:
D L, Sprecher, G L, Pearce
Publikováno v:
Journal of the American College of Cardiology. 36(4)
The aim of the study was to determine the value of a cluster of metabolic risk factors in predicting mortality after coronary artery bypass surgery (CABG).The "deadly quartet" of metabolic risk factors (i.e., obesity, diabetes, hypertension, and hype
Publikováno v:
The American journal of cardiology. 82(6)
We performed a multicenter, open-label study to determine the long-term safety and efficacy of a new extended-release once-a-night niacin preparation, Niaspan, in the treatment of hypercholesterolemia. Niaspan, 0.5 to 3.0 g once a night at bedtime, w
Publikováno v:
International journal of obesity and related metabolic disorders : journal of the International Association for the Study of Obesity. 20(8)
To examine the effect of gender on the relationship between obesity measures and lipids/lipoproteins.Cross-sectional, matched observational study of adult men and women.225 spousal pairs from Cincinnati, Ohio (age range, 28-66 years; mean +/- SD (yr)
Publikováno v:
Pediatrics. 94(6 Pt 1)
To determine whether lipid disorders can be predicted in parents after such disorders are identified initially in their children. Although this relation has been well determined for children with high cholesterol or low-density lipoprotein cholestero
Publikováno v:
Archives of family medicine. 3(8)
Objectives To determine how frequently lay consumers evaluate both the front label of a product package and other nutritional information on the back label of the package; whether the nutritional descriptors on the front label that concern fat affect